{"name":"NorthSea Therapeutics B.V.","slug":"northsea-therapeutics-b-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NST 6179","genericName":"NST 6179","slug":"nst-6179","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"NST 6179","genericName":"NST 6179","slug":"nst-6179","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNMTdNSDVvdEdiSFI0YUV5UTNaX3daVHowcURwNldBX2JFOTN6NnpISHRJdlU2a2lFc1gyOHBneExCcEhlbUVXdEFnRHE4MW5OMEhxSlM4a2hodTR4OE1LSUdXRFNiV3lvaXY4Y0hWbWVUaUtYTk1DVTVrYjRMNG9XTVlzVDFMYnNRUkZ1Y1BMVGpjRC1HZWVpaDUtV1gyMEpSQ0xkcjdha2VWUnFhbnVsTEJpbFFtRmVGdHdyZzlzTnZsTXhvNWZzdW15Z0dEZnZIMEx2OFZyV3dtQzN5U2RJdEpwRDVmclJMLWRmekZB0gHzAUFVX3lxTFAyZlcxOFNReTNsWlYySWtlU21FNTBRaXhFTzVpY2dLTVJ0WWhKSGIycTlTY1lrRV9kTVFFUXVmdzlnQVlJY05zdExFRktWYnlmQ1M5R1d2ME9SazNrTDR0cVJmeC11MTBHYjVSY2pxNnRualBCcHFSOC1xakxYVE5iVHEtV0hvcWRBZ3hqN0IwVFFfdnVQd2pORUZCc1M2UWZJQ0k3QTlNSmd4cUtoMUYxVEtBQ3hMZEVuY1hlQ3Y5NXhPb2tmanJ0UzN0Sk44anp0eDV1TWk0YjVOMWFIWTJMZ1lvdTNpX1A3TXNxZEprMTBvbw?oc=5","date":"2026-03-31","type":"pipeline","source":"The Manila Times","summary":"NorthSea Therapeutics Bolsters Board, as Orziloben Moves into Late-stage Development - The Manila Times","headline":"NorthSea Therapeutics Bolsters Board, as Orziloben Moves into Late-stage Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE56dDFDdXRNQ0s3Y3RuYU05Y3prSDdlTE9fdTJ4RG45Rm1RWXp1T244VVk1MTNNUFhib3RJQWU5R1VjWTlYUkNoQUdxVEtTTVk1ZHpUSTdESS1fTE9rc3ZQdEtoVjB6dTRkUEpBU0ZMRkFpT2d2Q0t2d204bHI?oc=5","date":"2026-01-13","type":"pipeline","source":"Labiotech.eu","summary":"Meet 7 biotech companies in the Netherlands changing the game - Labiotech.eu","headline":"Meet 7 biotech companies in the Netherlands changing the game","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOZVRUM09NbTMwZlBrNENqbXZUTnl1Y0VLajdSZG9iZGdfQ3Nabl95RFJ5R3F3UUVGRURYaFBsTmZRaDdoY21NWmU3WEhZWXBldmFiYk1QeEpjZGlwN2lvWWpvY1QyaUhIQVZ0MU9YOHNjbDR0d3ZSckNWVUZDUkx5dkl0NTAybjVfQ2Z2OVRLbUFKa2hRUEFOZ0lqQjl6aG9QYzJHQkZZNTBLYUdyZXNmcmRFaGhYQ29sOXhZQnJCOGlKa0VOOGR0STZzTFBmZW5QOE0xN3pKMGlLcV9XSFBGMGp4X05EUERPdHRsaE1SdmFBWFloM05vbTZXSFNFdw?oc=5","date":"2024-01-17","type":"pipeline","source":"IANS","summary":"Indo-Asian News Service - IANS","headline":"Indo-Asian News Service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1lQzBHZllROXdvNktCRUhuRURvM3pTdnAyN1hNb1RTR3Q4WlR6SERBcHJDX3NfQWlRT2ZwbDlMX2ljX19ReTZERWlaZU04Wllxb0ZCTVdEbXNhX1FyaWZwbjQ1SQ?oc=5","date":"2023-09-18","type":"trial","source":"Wiley Online Library","summary":"Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis - Wiley Online Library","headline":"Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed no","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNby1HdVlrTW9UOGRiR0ZEVXFfLUtBT3pxS21NbnA4ZXRGd2l6a2doWDlYN0d6eVBncG9aZEdOVUI1ZG50dFdoN2haVXprMGJaTDg3WkU2S3FWZEVqdjEyY2NCN0w4SVRNUWZ2Q29fakVGZmk2M2lYZHBpRXI1dDlDaENmOFRNV28zemd1eUhKWjdjbzlacHFtb1lrTzMyRGFjbEZmZXJ6OUpZTmV2SnpUUDVUNUcwNlpqb0hGU0xSaU4wY0dGVmtqQURnZ2lqcGtQX2FEd0F3?oc=5","date":"2022-11-08","type":"pipeline","source":"Healio","summary":"Efruxifermin induces NASH resolution, improves fibrosis by at least 1 stage vs. placebo - Healio","headline":"Efruxifermin induces NASH resolution, improves fibrosis by at least 1 stage vs. placebo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNdTBEenlFTE8xWkdKYnFwX2Z6Z3NVdWFvMURNZzdUV0N1R0Q4N0lQeW5wUHM0bnRsWk1laS1nTFFEcDBsR1NFbUJSemExb0pZM3dqalhVbXhneVE0Y3BTemtUVFhwZnN4WDNUdDhNbEo5d0J3Y2EtbkFHZDFaOHNmWi01NlhaN3RTVDQxMXZMSXpnanRBb0ZkVWhBWQ?oc=5","date":"2021-06-14","type":"pipeline","source":"EU-Startups","summary":"87 Top Health Care Startups and Companies in The Netherlands (2021) - EU-Startups","headline":"87 Top Health Care Startups and Companies in The Netherlands (2021) - EU","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}